Sunday, May 5, 2024
ADVT 
Health

Coffee may cut severity of fatty liver disease in diabetics

Darpan News Desk IANS, 12 Jan, 2023 01:44 PM
  • Coffee may cut severity of fatty liver disease in diabetics

Photo courtesy of IStock. 

Caffeine, polyphenols, and other natural products found in coffee may help reduce the severity of non-alcoholic fatty liver disease (NAFLD) among overweight people with type 2 diabetes (T2D), a new study has shown.

NAFLD is a collective term for liver disorders caused by a build-up of fat in the liver. These can lead to liver fibrosis, which can progress to cirrhosis (scarring of the liver) and liver cancer, according to a study by the Portugal-based University of Coimbra.

The main cause of NAFLD is not excessive alcohol consumption, but rather an unhealthy lifestyle with little physical activity and a high-calorie diet.

"Due to changes in modern diet and lifestyle, there is an increase in obesity rates and incidence of both T2D and NAFLD, which can ultimately develop into more severe and irreversible conditions, burdening healthcare systems," said the corresponding author of the study, John Griffith Jones, PhD, Senior Researcher at the University of Coimbra, Portugal.

"Our research is the first to observe that higher cumulative amounts of both caffeine and non-caffeine metabolites in urine are associated with a reduced severity of NAFLD in overweight people with T2D," he added.

In the study, participants who consumed more coffee had healthier livers, but subjects who consumed more caffeine were less likely to develop liver fibrosis, whereas patients who consumed more non-caffeine coffee components had a lower fatty liver index score.

The study suggests that for overweight type 2 diabetes patients, a higher intake of coffee is associated with less severe NAFLD.

Additionally, the study cited that other coffee components, including polyphenols, reduce oxidative stress in the liver, in turn reducing the risk of fibrosis as well as improving glucose homeostasis in both healthy and overweight subjects.

All these factors may also alleviate the severity of T2D, the study mentioned.

MORE Health ARTICLES

PepsiCo goes Beyond Meat in new partnership

PepsiCo goes Beyond Meat in new partnership
The join venture gives Pepsi access to one of the leading plant-based meat companies at a time when consumers are increasingly cutting back on meat consumption and looking for healthier, more sustainable foods.

PepsiCo goes Beyond Meat in new partnership

A new COVID-19 challenge: Mutations rise along with cases

A new COVID-19 challenge: Mutations rise along with cases
Each new infection gives the virus a chance to mutate as it makes copies of itself, threatening to undo the progress made so far to control the pandemic.

A new COVID-19 challenge: Mutations rise along with cases

Docs urge pregnant women to get vaccinated

Docs urge pregnant women to get vaccinated
Dr. Samantha Hill, a cardiac surgeon in Toronto, says because pregnant and breastfeeding women haven't been included in clinical trials yet she is worried the message many pregnant women are getting is to not get vaccinated.

Docs urge pregnant women to get vaccinated

First blood test to help diagnose Alzheimer's goes on sale

First blood test to help diagnose Alzheimer's goes on sale
More than 5 million people in the United States and millions more around the world have Alzheimer’s, the most common form of dementia.

First blood test to help diagnose Alzheimer's goes on sale

What does emergency use of a COVID-19 vaccine mean?

What does emergency use of a COVID-19 vaccine mean?
Before any vaccine is permitted in the U.S., it must be reviewed by the Food and Drug Administration, which requires study in thousands of people.

What does emergency use of a COVID-19 vaccine mean?

Pfizer issues more promising vaccine results

Pfizer issues more promising vaccine results
Pfizer and its German partner BioNTech just last week estimated the vaccine was more than 90 per cent effective after 94 infections had been counted in a study that included 44,000 people.

Pfizer issues more promising vaccine results